Potent neutralizing monoclonal antibodies against Ebola virus infection

Ebola virus infections cause a deadly hemorrhagic disease for which no vaccines or therapeutics has received regulatory approval. Here we show isolation of three (Q206, Q314 and Q411) neutralizing monoclonal antibodies (mAbs) against the surface glycoprotein (GP) of Ebola virus identified in West Af...

Full description

Bibliographic Details
Main Authors: Zhang, Qi, Gui, Miao, Niu, Xuefeng, He, Shihua, Wang, Ruoke, Feng, Yupeng, Kroeker, Andrea, Zuo, Yanan, Wang, Hua, Wang, Ying, Li, Jiade, Li, Chufang, Shi, Yi, Shi, Xuanling, Gao, George F., Xiang, Ye, Qiu, Xiangguo, Chen, Ling, Zhang, Linqi
Format: Online
Language:English
Published: Nature Publishing Group 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867612/